NDC 0093-5955

Arformoterol tartrate

Arformoterol Tartrate

Arformoterol tartrate is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Arformoterol Tartrate.

Product ID0093-5955_4e40d2a6-f733-460e-a6f5-c78c9241468e
NDC0093-5955
Product TypeHuman Prescription Drug
Proprietary NameArformoterol tartrate
Generic NameArformoterol Tartrate
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2021-12-06
Marketing CategoryANDA /
Application NumberANDA200293
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameARFORMOTEROL TARTRATE
Active Ingredient Strength15 ug/2mL
Pharm ClassesAdrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0093-5955-06

12 POUCH in 1 CARTON (0093-5955-06) > 5 AMPULE in 1 POUCH (0093-5955-45) > 2 mL in 1 AMPULE (0093-5955-19)
Marketing Start Date2021-12-06
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Arformoterol tartrate" or generic name "Arformoterol Tartrate"

NDCBrand NameGeneric Name
0093-5955Arformoterol tartrateArformoterol tartrate
62332-633Arformoterol tartrateArformoterol tartrate
62756-277Arformoterol TartrateArformoterol Tartrate
68462-833ARFORMOTEROL TARTRATEarformoterol tartrate
69097-168arformoterol tartratearformoterol tartrate
70748-175Arformoterol tartrateArformoterol tartrate
70748-257Arformoterol TartrateArformoterol Tartrate
70756-612arformoterol tartratearformoterol tartrate
63402-911Brovanaarformoterol tartrate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.